Overview
- Published in Nature Communications, the Canadian study analyzed follicular fluid from about 1,000 IVF patients and detected THC in samples from 62 women.
- The THC-positive group showed faster oocyte maturation and produced fewer euploid embryos suitable for IVF compared with THC-negative patients.
- In laboratory tests, adding THC altered gene expression tied to inflammation and chromosome segregation and disrupted the spindle apparatus during cell division.
- Experts say these mechanisms are biologically plausible pathways to aneuploidy, embryo rejection and early miscarriage, but they caution against overgeneralizing the results.
- Clinicians note key gaps—IVF-only population, no data on dose, timing or mode of use, and no age stratification—and recommend counseling patients to avoid cannabis and standardizing questions about use in fertility care.